For administration as a self-propelled dosage unit for administering the active ingredient in aerosol form suitable for inhalation thereapythe composition can comprise the active ingredient suspended in an inert propellant (such as a mixture of dichlorodifluoromethane and dichlorotetrafluoroethane) together with a co-solvent, such as ethanol, flavoring materials and stabilizers.